Corline Biomedical AB EBIT for the year ending December 31, 2024: USD -2.08 M

Corline Biomedical AB EBIT is USD -2.08 M for the year ending December 31, 2024, a 1,084.54% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Corline Biomedical AB EBIT for the year ending December 31, 2023 was USD -175.98 K, a -179.12% change year over year.
  • Corline Biomedical AB EBIT for the year ending December 31, 2022 was USD 222.42 K, a -129.24% change year over year.
  • Corline Biomedical AB EBIT for the year ending December 31, 2021 was USD -760.68 K, a -13.85% change year over year.
  • Corline Biomedical AB EBIT for the year ending December 31, 2020 was USD -882.94 K, a -13.02% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)